Viewing Study NCT03312751


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-12 @ 4:08 PM
Study NCT ID: NCT03312751
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2017-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis
Sponsor: Swedish Orphan Biovitrum
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Hemophagocytic Lymphohistiocytosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Interferon-gamma View
None NI-0501 View
None primary HLH View
None emapalumab View